Gufic Biosciences Limited engages in manufacture and marketing of active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac, infertility, antiviral, and proton-pump inhibitor segments. In addition, it offers spark, criti care, and ferticare pharmaceutical products; and herbal and personal care products. The company supplies its products to hospital chains and medical facilities. It also exports its products to more than 20 countries. The company was founded in 1970 and is based in Mumbai, India.

NSE:GUFICBIO

Gufic Biosciences Limited

Last Close

343.20

21/05 06:40

Market Cap

34.80B

Beta: 0.79

Volume Today

54.44K

Avg: 85.49K

PE Ratio

39.21

PFCF: -

Dividend Yield

0.03%

Payout:0%

Financials Not Available